Shreya Gopalakrishnan

Shreya Gopalakrishnan

Auto-generated profile, based on publicly available information

Shreya Gopalakrishnan

Center for Regenerative Therapies, Technische Universität (TU) Dresden, 01307 Dresden, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in Science Immunology
Verified
Journal Article
Closed access
ASAnne Strigli
Anne Strigli
SGShreya Gopalakrishnan
Shreya Gopalakrishnan
YZYvonne Zeissig
Yvonne Zeissig
MBMarijana Basic
Marijana Basic
JWJun Wang
Jun Wang
SZSebastian Zeissig
Sebastian Zeissig
Deficiency in XIAP is associated with Paneth cell defects and susceptibility to microbiota-dependent intestinal inflammation.

25 January 2019 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
SGS Gopalakrishnan
S Gopalakrishnan
YZY Zeissig
Y Zeissig
ASA Strigli
A Strigli
MBMarijana Basic
Marijana Basic
JHJ Hartwig
J Hartwig
SZS Zeissig
S Zeissig
Mendelian forms of IBD have provided novel insight into the mechanisms underlying intestinal inflammation in IBD. We and others have recently described mutations in the gene encoding X-linked inhibitor of apoptosis protein (XIAP) as the basis for a novel Mendelian form of Crohn’s disease (CD). However, the mechanisms through which XIAP deficiency promotes intestinal inflammation are unknown. Here, we investigated the pathways that link XIAP defects and intestinal inflammation using mice deficient in XIAP. Xiap−/− mice and wild-type (WT) littermates were analysed under constitutive conditions as well as upon exposure to the pathobiont Helicobacter hepaticus. Xiap−/− mice showed a reduced number of Paneth cells (PCs) in the ileum as a consequence of increased PC death, in line with the role of XIAP as an inhibitor of effector caspases. Increased cell death was specific to PCs and not observed for other secretory or absorptive intestinal epithelial cells. The loss of PCs was associated with reduced abundance of antimicrobial peptides in the ileum and colon, impaired bacterial control, and dense colonisation of intestinal crypts by commensal bacteria as well as an increased number of mucosa-adherent bacteria. In addition, we observed alterations in the composition of the microbiota in Xiap−/− mice with an increased relative abundance of Deltaproteobacteria including increased abundance of the pathobiont Bilophila wadsworthia. While these alterations in PCs and bacterial control were insufficient to elicit spontaneous intestinal inflammation under specific pathogen-free (SPF) conditions, exposure to the pathobiont Helicobacter hepaticus led to granulomatous ileitis in Xiap−/− mice but not WT littermates. Our results demonstrate that XIAP deficiency is associated with susceptibility to microbiota-induced intestinal inflammation. These findings reinforce the notion of a critical role of PC defects and altered host–microbial interactions in the pathogenesis of CD, provide a mechanistic explanation to incomplete penetrance of CD in patients with XIAP mutations, and highlight the microbiota as a potential therapeutic target in patients with XIAP mutations and CD.